• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiplatform Genomic Roadmap of Hepatocellular Carcinoma: A Matter of Molecular Heterogeneity.

作者信息

Woo Hyun Goo, Kim Yoon Jun

机构信息

Department of Physiology, Ajou University School of Medicine, Suwon, Republic of Korea.

Department of Biomedical Sciences, Graduate School Ajou University, Suwon, Republic of Korea.

出版信息

Hepatology. 2018 Nov;68(5):2029-2032. doi: 10.1002/hep.29925. Epub 2018 Sep 24.

DOI:10.1002/hep.29925
PMID:29637589
Abstract
摘要

相似文献

1
Multiplatform Genomic Roadmap of Hepatocellular Carcinoma: A Matter of Molecular Heterogeneity.肝细胞癌的多平台基因组路线图：分子异质性问题
Hepatology. 2018 Nov;68(5):2029-2032. doi: 10.1002/hep.29925. Epub 2018 Sep 24.
2
Genomic decoding of hepatocellular carcinoma.肝细胞癌的基因组解码
Gastroenterology. 2006 Oct;131(4):1344-6. doi: 10.1053/j.gastro.2006.08.060.
3
Liver cancer: Translating '-omics' results into precision medicine for hepatocellular carcinoma.肝癌：将“组学”结果转化为肝细胞癌的精准医学
Nat Rev Gastroenterol Hepatol. 2017 Oct;14(10):571-572. doi: 10.1038/nrgastro.2017.103. Epub 2017 Aug 2.
4
Genomic heterogeneity: next-generation sequencing enables biomarker identification for hepatocellular carcinoma.基因组异质性：新一代测序技术助力肝细胞癌生物标志物的识别。
Biomark Med. 2017 Jul;11(7):515-518. doi: 10.2217/bmm-2017-0121. Epub 2017 Jul 12.
5
Hepatocellular carcinoma in 2011: Genomics in hepatocellular carcinoma--a big step forward.2011年肝细胞癌：肝细胞癌的基因组学——向前迈进一大步。
Nat Rev Gastroenterol Hepatol. 2012 Jan 10;9(2):69-70. doi: 10.1038/nrgastro.2011.255.
6
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.纤维板层型肝细胞癌的基因组图谱：十位患者的全基因组测序
Oncotarget. 2015 Jan 20;6(2):755-70. doi: 10.18632/oncotarget.2712.
7
TERT promoter mutation during development of hepatoblastoma to hepatocellular carcinoma.
J Hepatol. 2015 Feb;62(2):497. doi: 10.1016/j.jhep.2014.10.045. Epub 2014 Nov 5.
8
Reply to: "TERT promoter mutation during development of hepatoblastoma to hepatocellular carcinoma".
J Hepatol. 2015 Feb;62(2):498-9. doi: 10.1016/j.jhep.2014.10.043. Epub 2014 Nov 5.
9
Hepatocellular carcinoma: genome-scale metabolic models for hepatocellular carcinoma.肝细胞癌：用于肝细胞癌的基因组规模代谢模型。
Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):336-7. doi: 10.1038/nrgastro.2014.70. Epub 2014 May 20.
10
[Genomic prognostic markers in hepatocellular carcinoma].
Gastroenterol Hepatol. 2012 Feb;35(2):94-101. doi: 10.1016/j.gastrohep.2011.10.003. Epub 2011 Dec 16.

引用本文的文献

1
Deciphering the oncogenic potential of ADAM9 in hepatocellular carcinoma through bioinformatics and experimental approaches.通过生物信息学和实验方法解析 ADAM9 在肝细胞癌中的致癌潜能。
Sci Rep. 2024 Nov 2;14(1):26432. doi: 10.1038/s41598-024-74650-8.
2
Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma.人工智能和复杂网络方法揭示了肝细胞癌的潜在基因生物标志物。
Int J Mol Sci. 2023 Oct 18;24(20):15286. doi: 10.3390/ijms242015286.
3
Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma.
用于肝细胞癌风险分层的N7-甲基鸟苷相关长链非编码RNA的鉴定
J Gastrointest Oncol. 2023 Jun 30;14(3):1392-1411. doi: 10.21037/jgo-23-227. Epub 2023 Jun 7.
4
Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma.一种对肝细胞癌具有预后和诊断价值的双lncRNA特征的鉴定
J Oncol. 2022 Jul 21;2022:2687455. doi: 10.1155/2022/2687455. eCollection 2022.
5
Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma.基于新型 γδ T 细胞的预后标志物用于评估肝细胞癌的风险和辅助治疗。
BMC Cancer. 2022 Jun 10;22(1):638. doi: 10.1186/s12885-022-09662-6.
6
PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma.PI3K/AKT/mTOR 通路相关基因揭示了与肝细胞癌免疫浸润相关的潜在预后特征。
Dis Markers. 2022 May 9;2022:7545666. doi: 10.1155/2022/7545666. eCollection 2022.
7
Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma.免疫相关的长链非编码RNA对预测肝细胞癌的预后和治疗反应
Sci Rep. 2022 Mar 11;12(1):4259. doi: 10.1038/s41598-022-08225-w.
8
Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma.ceRNA网络在肝细胞癌免疫浸润中的预后作用
Front Genet. 2021 Sep 13;12:739975. doi: 10.3389/fgene.2021.739975. eCollection 2021.
9
Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy.肝细胞癌中用于辅助免疫治疗的预后性m6A RNA甲基化调节因子图谱
Front Cell Dev Biol. 2021 Aug 5;9:669145. doi: 10.3389/fcell.2021.669145. eCollection 2021.
10
Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.基于肝癌干细胞特征的预后标志物的免疫价值
Front Cell Dev Biol. 2021 Aug 2;9:710207. doi: 10.3389/fcell.2021.710207. eCollection 2021.